LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Metrochem API Private Limited
03 1Seqens
04 1HRV Global Life Sciences
05 13M Company
06 1AXYNTIS Group
07 1Amsa Spa
08 1Artis Biotech
09 1Aurobindo Pharma Limited
10 1Aurore Life Sciences
11 2CHEMO
12 1Emcure Pharmaceuticals
13 1Grindeks AS
14 1Hoventa Pharma
15 1MSN Laboratories
16 3Maprimed
17 1Micro Labs Limited
18 1Omsav Pharma Research
19 1Piramal Pharma Solutions
20 2Solara Active Pharma Sciences
21 2Unimark Remedies Limited
01 3Argentina
02 2France
03 14India
04 1Italy
05 1Latvia
06 2Spain
07 3U.S.A
01 10Active
02 3Inactive
03 13Blank
01 2Suspended by Holder
02 9Valid
03 2Withdrawn by Holder
04 13Blank
01 1223MF10093
02 25Blank
01 1WC-0120
02 1WC-0123
03 1WC-0170
04 1WC-0226
05 1WC-0294
06 1WC-0294A1
07 20Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15244
Submission : 2001-01-15
Status : Inactive
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-06
Pay. Date : 2022-07-01
DMF Number : 37212
Submission : 2022-06-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33666
Submission : 2019-03-29
Status : Active
Type : II
Certificate Number : CEP 2020-054 - Rev 02
Issue Date : 2024-05-30
Type : Chemical
Substance Number : 1324
Status : Valid
Date of Issue : 2021-08-06
Valid Till : 2024-03-04
Written Confirmation Number : WC-0294
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10688
Submission : 1994-01-24
Status : Active
Type : II
Certificate Number : CEP 2013-145 - Rev 02
Issue Date : 2023-12-05
Type : Chemical
Substance Number : 1324
Status : Valid
NDC Package Code : 57741-0800
Start Marketing Date : 1985-10-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19272
Submission : 2006-03-23
Status : Active
Type : II
Certificate Number : R1-CEP 2009-289 - Rev 01
Issue Date : 2015-03-19
Type : Chemical
Substance Number : 1324
Status : Suspended by Holder
Date of Issue : 2024-04-23
Valid Till : 2027-04-22
Written Confirmation Number : WC-0170
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-07
Pay. Date : 2014-02-01
DMF Number : 23192
Submission : 2009-10-14
Status : Active
Type : II
Certificate Number : R1-CEP 2006-005 - Rev 02
Issue Date : 2020-08-13
Type : Chemical
Substance Number : 1324
Status : Suspended by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14749
Submission : 2000-02-29
Status : Active
Type : II
Certificate Number : CEP 2009-363 - Rev 03
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 1324
Status : Valid
Registration Number : 223MF10093
Registrant's Address : VIALE DEL GHISALLO, 20 20151 MILAN ITALY
Initial Date of Registration : 2011-06-29
Latest Date of Registration : --
NDC Package Code : 17373-1283
Start Marketing Date : 2009-07-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
We have 21 companies offering Flecainide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?